Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Glenmark’s stunning Q1 performance: How the pharma powerhouse is dominating global markets Glenmark Pharmaceuticals Limited (Glenmark) has announced impressive financial results for the first quarter of FY 2024-25, marked by… byPallavi MadhirajuAugust 16, 2024